APO Research
Talk to an analyst

APO RESEARCH · REPORT

Indocyanine Green

Indocyanine green (ICG) a cyanine dye used in medical diagnostics to determine cardiac output, hepatic function, and liver blood flow, and for ophthalmic angiography. It is a sterile, lyophilized green powder with a peak spectral absorption at 800 nm. These infrared frequencies penetrate retinal layers, allowing ICG angiography to image deeper patterns of circulation than fluorescein angiography.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Indocyanine green (ICG) a cyanine dye used in medical diagnostics to determine cardiac output, hepatic function, and liver blood flow, and for ophthalmic angiography. It is a sterile, lyophilized green powder with a peak spectral absorption at 800 nm. These infrared frequencies penetrate retinal layers, allowing ICG angiography to image deeper patterns of circulation than fluorescein angiography.

Selected research

Market Structure

Global Indocyanine Green Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025183 pages

Choose your research edition.

Industry ResearchIndocyanine Green Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Indocyanine Green Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Indocyanine Green Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Indocyanine Green Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Indocyanine Green Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

Indocyanine green (ICG) a cyanine dye used in medical diagnostics to determine cardiac output, hepatic function, and liver blood flow, and for ophthalmic angiography. It is a sterile, lyophilized green powder with a peak spectral absorption at 800 nm. These infrared frequencies penetrate retinal layers, allowing ICG angiography to image deeper patterns of circulation than fluorescein angiography.

Europe is the largest market with about 52% market share. USA and China are follower, accounting for about 33% market share.

The key players are Akorn, PULSION Medical Systems AG, Diagnostic Green, SERB, Daiichi Sankyo Company, Santen Pharmaceutical Co., Ltd., Aurolab, Yichuang, Eisai etc. Top 3 companies occupied about 60% market share.

Read the full market overview

This report provides an overview of the global Indocyanine Green market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Indocyanine Green and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Indocyanine Green sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Indocyanine Green market size, projected growth trends, production technologies, key applications, and end-use industries.

Indocyanine Green Segment by Company

Akorn

PULSION Medical Systems AG

Diagnostic Green

SERB

Daiichi Sankyo Company

Santen Pharmaceutical Co., Ltd.

Aurolab

Yichuang

Eisai

Indocyanine Green Segment by Type

Type I

Type II

Indocyanine Green Segment by Application

Ophthalmology

Neurosurgery

Liver Diseases

Others

Indocyanine Green Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Indocyanine Green market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Indocyanine Green and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Indocyanine Green.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Indocyanine Green market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Indocyanine Green manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Indocyanine Green in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Indocyanine Green in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Indocyanine Green Industry Trends Table 2. Indocyanine Green Industry Drivers Table 3. Indocyanine Green Industry Opportunities and Challenges Table 4. Indocyanine Green Industry Restraints Table 5. Global Indocyanine Green Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Indocyanine Green Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Indocyanine Green Sales by Manufacturers (K Nos) & (2021-2026) Table 8. Global Indocyanine Green Sales Market Share by Manufacturers Table 9. Global Indocyanine Green Average Sales Price (USD/Nos) of Manufacturers (2021-2026) Table 10. Global Indocyanine Green Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Indocyanine Green Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Indocyanine Green Manufacturers, Product Type & Application Table 13. Global Indocyanine Green Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Indocyanine Green by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Type I Table 17. Major Manufacturers of Type II Table 18. Global Indocyanine Green Sales by Type 2021 VS 2025 VS 2032 (K Nos) Table 19. Global Indocyanine Green Sales by Type (2021-2026) & (K Nos) Table 20. Global Indocyanine Green Sales by Type (2027-2032) & (K Nos) Table 21. Global Indocyanine Green Sales Market Share by Type (2021-2026) Table 22. Global Indocyanine Green Sales Market Share by Type (2027-2032) Table 23. Global Indocyanine Green Revenue by Type 2021 VS 2025 VS 2032 (K Nos) Table 24. Global Indocyanine Green Revenue by Type (2021-2026) & (K Nos) Table 25. Global Indocyanine Green Revenue by Type (2027-2032) & (K Nos) Table 26. Global Indocyanine Green Revenue Market Share by Type (2021-2026) Table 27. Global Indocyanine Green Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Ophthalmology Table 29. Major Manufacturers of Neurosurgery Table 30. Major Manufacturers of Liver Diseases Table 31. Major Manufacturers of Others Table 32. Global Indocyanine Green Sales by Application 2021 VS 2025 VS 2032 (K Nos) Table 33. Global Indocyanine Green Sales by Application (2021-2026) & (K Nos) Table 34. Global Indocyanine Green Sales by Application (2027-2032) & (K Nos) Table 35. Global Indocyanine Green Sales Market Share by Application (2021-2026) Table 36. Global Indocyanine Green Sales Market Share by Application (2027-2032) Table 37. Global Indocyanine Green Revenue by Application 2021 VS 2025 VS 2032 (K Nos) Table 38. Global Indocyanine Green Revenue by Application (2021-2026) & (K Nos) Table 39. Global Indocyanine Green Revenue by Application (2027-2032) & (K Nos) Table 40. Global Indocyanine Green Revenue Market Share by Application (2021-2026) Table 41. Global Indocyanine Green Revenue Market Share by Application (2027-2032) Table 42. Global Indocyanine Green Sales by Region: 2021 VS 2025 VS 2032 (K Nos) Table 43. Global Indocyanine Green Sales by Region (2021-2026) & (K Nos) Table 44. Global Indocyanine Green Sales Market Share by Region (2021-2026) Table 45. Global Indocyanine Green Sales Forecasted by Region (2027-2032) & (K Nos) Table 46. Global Indocyanine Green Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Indocyanine Green Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Nos) Table 48. North America Indocyanine Green Sales by Country (2021-2026) & (K Nos) Table 49. North America Indocyanine Green Sales by Country (2027-2032) & (K Nos) Table 50. Europe Indocyanine Green Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Nos) Table 51. Europe Indocyanine Green Sales by Country (2021-2026) & (K Nos) Table 52. Europe Indocyanine Green Sales by Country (2027-2032) & (K Nos) Table 53. Asia Pacific Indocyanine Green Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Nos) Table 54. Asia Pacific Indocyanine Green Sales by Country (2021-2026) & (K Nos) Table 55. Asia Pacific Indocyanine Green Sales by Country (2027-2032) & (K Nos) Table 56. South America, Middle East and Africa Indocyanine Green Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Nos) Table 57. South America, Middle East and Africa Indocyanine Green Sales by Country (2021-2026) & (K Nos) Table 58. South America, Middle East and Africa Indocyanine Green Sales by Country (2027-2032) & (K Nos) Table 59. Global Indocyanine Green Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Indocyanine Green Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Indocyanine Green Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Indocyanine Green Revenue Market Share by Region (2021-2026) Table 63. Global Indocyanine Green Revenue Market Share by Region (2027-2032) Table 64. Akorn Company Information Table 65. Akorn Business Overview Table 66. Akorn Indocyanine Green Sales (K Nos), Price (USD/Nos), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Akorn Indocyanine Green Product Portfolio Table 68. Akorn Recent Development Table 69. PULSION Medical Systems AG Company Information Table 70. PULSION Medical Systems AG Business Overview Table 71. PULSION Medical Systems AG Indocyanine Green Sales (K Nos), Price (USD/Nos), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. PULSION Medical Systems AG Indocyanine Green Product Portfolio Table 73. PULSION Medical Systems AG Recent Development Table 74. Diagnostic Green Company Information Table 75. Diagnostic Green Business Overview Table 76. Diagnostic Green Indocyanine Green Sales (K Nos), Price (USD/Nos), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Diagnostic Green Indocyanine Green Product Portfolio Table 78. Diagnostic Green Recent Development Table 79. SERB Company Information Table 80. SERB Business Overview Table 81. SERB Indocyanine Green Sales (K Nos), Price (USD/Nos), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. SERB Indocyanine Green Product Portfolio Table 83. SERB Recent Development Table 84. Daiichi Sankyo Company Company Information Table 85. Daiichi Sankyo Company Business Overview Table 86. Daiichi Sankyo Company Indocyanine Green Sales (K Nos), Price (USD/Nos), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Daiichi Sankyo Company Indocyanine Green Product Portfolio Table 88. Daiichi Sankyo Company Recent Development Table 89. Santen Pharmaceutical Co., Ltd. Company Information Table 90. Santen Pharmaceutical Co., Ltd. Business Overview Table 91. Santen Pharmaceutical Co., Ltd. Indocyanine Green Sales (K Nos), Price (USD/Nos), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Santen Pharmaceutical Co., Ltd. Indocyanine Green Product Portfolio Table 93. Santen Pharmaceutical Co., Ltd. Recent Development Table 94. Aurolab Company Information Table 95. Aurolab Business Overview Table 96. Aurolab Indocyanine Green Sales (K Nos), Price (USD/Nos), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Aurolab Indocyanine Green Product Portfolio Table 98. Aurolab Recent Development Table 99. Yichuang Company Information Table 100. Yichuang Business Overview Table 101. Yichuang Indocyanine Green Sales (K Nos), Price (USD/Nos), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Yichuang Indocyanine Green Product Portfolio Table 103. Yichuang Recent Development Table 104. Eisai Company Information Table 105. Eisai Business Overview Table 106. Eisai Indocyanine Green Sales (K Nos), Price (USD/Nos), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Eisai Indocyanine Green Product Portfolio Table 108. Eisai Recent Development Table 109. Key Raw Materials Table 110. Raw Materials Key Suppliers Table 111. Indocyanine Green Distributors List Table 112. Indocyanine Green Customers List Table 113. Research Programs/Design for This Report Table 114. Authors List of This Report Table 115. Secondary Sources Table 116. Primary Sources List of Figures Figure 1. Indocyanine Green Product Image Figure 2. Global Indocyanine Green Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Indocyanine Green Market Size (2021-2032) & (US$ Million) Figure 4. Global Indocyanine Green Sales (2021-2032) & (K Nos) Figure 5. Global Indocyanine Green Average Price (USD/Nos) & (2021-2032) Figure 6. Global Top 5 and 10 Indocyanine Green Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Type I Image Figure 9. Type II Image Figure 10. Global Indocyanine Green Sales by Type (2021 VS 2025 VS 2032) & (K Nos) Figure 11. Global Indocyanine Green Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Indocyanine Green Sales Market Share by Type (2021-2032) Figure 13. Global Indocyanine Green Revenue by Type (2021 VS 2025 VS 2032) & (K Nos) Figure 14. Global Indocyanine Green Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Indocyanine Green Revenue Market Share by Type (2021-2032) Figure 16. Ophthalmology Image Figure 17. Neurosurgery Image Figure 18. Liver Diseases Image Figure 19. Others Image Figure 20. Global Indocyanine Green Sales by Application (2021 VS 2025 VS 2032) & (K Nos) Figure 21. Global Indocyanine Green Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Indocyanine Green Sales Market Share by Application (2021-2032) Figure 23. Global Indocyanine Green Revenue by Application (2021 VS 2025 VS 2032) & (K Nos) Figure 24. Global Indocyanine Green Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Indocyanine Green Revenue Market Share by Application (2021-2032) Figure 26. North America Indocyanine Green Sales and Growth Rate (2021-2032) & (K Nos) Figure 27. North America Indocyanine Green Sales Market Share by Country (2021-2032) Figure 28. U.S. Indocyanine Green Sales and Growth Rate (2021-2032) & (K Nos) Figure 29. Canada Indocyanine Green Sales and Growth Rate (2021-2032) & (K Nos) Figure 30. Mexico Indocyanine Green Sales and Growth Rate (2021-2032) & (K Nos) Figure 31. Europe Indocyanine Green Sales and Growth Rate (2021-2032) & (K Nos) Figure 32. Europe Indocyanine Green Sales Market Share by Country (2021-2032) Figure 33. Germany Indocyanine Green Sales and Growth Rate (2021-2032) & (K Nos) Figure 34. France Indocyanine Green Sales and Growth Rate (2021-2032) & (K Nos) Figure 35. U.K. Indocyanine Green Sales and Growth Rate (2021-2032) & (K Nos) Figure 36. Italy Indocyanine Green Sales and Growth Rate (2021-2032) & (K Nos) Figure 37. Netherlands Indocyanine Green Sales and Growth Rate (2021-2032) & (K Nos) Figure 38. Asia Pacific Indocyanine Green Sales and Growth Rate (2021-2032) & (K Nos) Figure 39. Asia Pacific Indocyanine Green Sales Market Share by Country (2021-2032) Figure 40. China Indocyanine Green Sales and Growth Rate (2021-2032) & (K Nos) Figure 41. Japan Indocyanine Green Sales and Growth Rate (2021-2032) & (K Nos) Figure 42. South Korea Indocyanine Green Sales and Growth Rate (2021-2032) & (K Nos) Figure 43. Southeast Asia Indocyanine Green Sales and Growth Rate (2021-2032) & (K Nos) Figure 44. India Indocyanine Green Sales and Growth Rate (2021-2032) & (K Nos) Figure 45. Australia Indocyanine Green Sales and Growth Rate (2021-2032) & (K Nos) Figure 46. South America, Middle East and Africa Indocyanine Green Sales and Growth Rate (2021-2032) & (K Nos) Figure 47. South America, Middle East and Africa Indocyanine Green Sales Market Share by Country (2021-2032) Figure 48. Brazil Indocyanine Green Sales and Growth Rate (2021-2032) & (K Nos) Figure 49. South Africa Indocyanine Green Sales and Growth Rate (2021-2032) & (K Nos) Figure 50. Saudi Arabia Indocyanine Green Sales and Growth Rate (2021-2032) & (K Nos) Figure 51. Turkey Indocyanine Green Sales and Growth Rate (2021-2032) & (K Nos) Figure 52. Argentina Indocyanine Green Sales and Growth Rate (2021-2032) & (K Nos) Figure 53. UAE Indocyanine Green Sales and Growth Rate (2021-2032) & (K Nos) Figure 54. Egypt Indocyanine Green Sales and Growth Rate (2021-2032) & (K Nos) Figure 55. Chile Indocyanine Green Sales and Growth Rate (2021-2032) & (K Nos) Figure 56. Global Indocyanine Green Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Indocyanine Green Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Indocyanine Green Revenue (2021-2032) & (US$ Million) Figure 59. North America Indocyanine Green Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Indocyanine Green Revenue (2021-2032) & (US$ Million) Figure 61. Europe Indocyanine Green Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Indocyanine Green Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Indocyanine Green Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Indocyanine Green Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Indocyanine Green Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Indocyanine Green Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Indocyanine Green Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Type I
  • Type II
Applications
  • Ophthalmology
  • Neurosurgery
  • Liver Diseases
  • Others
Companies covered
  • Akorn
  • PULSION Medical Systems AG
  • Diagnostic Green
  • SERB
  • Daiichi Sankyo Company
  • Santen Pharmaceutical Co., Ltd.
  • Aurolab
  • Yichuang
  • Eisai

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Indocyanine Green Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Indocyanine Green Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Indocyanine Green Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Indocyanine Green Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Indocyanine Green Market Dynamics
  1. 2.1 Indocyanine Green Industry Trends
  2. 2.2 Indocyanine Green Industry Drivers
  3. 2.3 Indocyanine Green Industry Opportunities and Challenges
  4. 2.4 Indocyanine Green Industry Restraints
3 Indocyanine Green Market by Manufacturers
  1. 3.1 Global Indocyanine Green Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Indocyanine Green Sales by Manufacturers (2021-2026)
  3. 3.3 Global Indocyanine Green Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Indocyanine Green Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Indocyanine Green Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Indocyanine Green Manufacturers, Product Type & Application
  7. 3.7 Global Indocyanine Green Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Indocyanine Green Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Indocyanine Green Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Indocyanine Green Tier 1, Tier 2, and Tier 3
4 Indocyanine Green Market by Type
  1. 4.1 Indocyanine Green Type Introduction
  2. 4.1.1 Type I
  3. 4.1.2 Type II
  4. 4.2 Global Indocyanine Green Sales by Type
  5. 4.2.1 Global Indocyanine Green Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Indocyanine Green Sales by Type (2021-2032)
  7. 4.2.3 Global Indocyanine Green Sales Market Share by Type (2021-2032)
  8. 4.3 Global Indocyanine Green Revenue by Type
  9. 4.3.1 Global Indocyanine Green Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Indocyanine Green Revenue by Type (2021-2032)
  11. 4.3.3 Global Indocyanine Green Revenue Market Share by Type (2021-2032)
5 Indocyanine Green Market by Application
  1. 5.1 Indocyanine Green Application Introduction
  2. 5.1.1 Ophthalmology
  3. 5.1.2 Neurosurgery
  4. 5.1.3 Liver Diseases
  5. 5.1.4 Others
  6. 5.2 Global Indocyanine Green Sales by Application
  7. 5.2.1 Global Indocyanine Green Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Indocyanine Green Sales by Application (2021-2032)
  9. 5.2.3 Global Indocyanine Green Sales Market Share by Application (2021-2032)
  10. 5.3 Global Indocyanine Green Revenue by Application
  11. 5.3.1 Global Indocyanine Green Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Indocyanine Green Revenue by Application (2021-2032)
  13. 5.3.3 Global Indocyanine Green Revenue Market Share by Application (2021-2032)
6 Global Indocyanine Green Sales by Region
  1. 6.1 Global Indocyanine Green Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Indocyanine Green Sales by Region (2021-2032)
  3. 6.2.1 Global Indocyanine Green Sales by Region (2021-2026)
  4. 6.2.2 Global Indocyanine Green Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Indocyanine Green Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Indocyanine Green Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Indocyanine Green Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Indocyanine Green Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Indocyanine Green Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Indocyanine Green Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Indocyanine Green Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Indocyanine Green Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Indocyanine Green Revenue by Region
  1. 7.1 Global Indocyanine Green Revenue by Region
  2. 7.1.1 Global Indocyanine Green Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Indocyanine Green Revenue by Region (2021-2026)
  4. 7.1.3 Global Indocyanine Green Revenue by Region (2027-2032)
  5. 7.1.4 Global Indocyanine Green Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Indocyanine Green Revenue (2021-2032)
  8. 7.2.2 North America Indocyanine Green Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Indocyanine Green Revenue (2021-2032)
  11. 7.3.2 Europe Indocyanine Green Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Indocyanine Green Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Indocyanine Green Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Indocyanine Green Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Indocyanine Green Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Akorn
  2. 8.1.1 Akorn Company Information
  3. 8.1.2 Akorn Business Overview
  4. 8.1.3 Akorn Indocyanine Green Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Akorn Indocyanine Green Product Portfolio
  6. 8.1.5 Akorn Recent Developments
  7. 8.2 PULSION Medical Systems AG
  8. 8.2.1 PULSION Medical Systems AG Company Information
  9. 8.2.2 PULSION Medical Systems AG Business Overview
  10. 8.2.3 PULSION Medical Systems AG Indocyanine Green Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 PULSION Medical Systems AG Indocyanine Green Product Portfolio
  12. 8.2.5 PULSION Medical Systems AG Recent Developments
  13. 8.3 Diagnostic Green
  14. 8.3.1 Diagnostic Green Company Information
  15. 8.3.2 Diagnostic Green Business Overview
  16. 8.3.3 Diagnostic Green Indocyanine Green Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Diagnostic Green Indocyanine Green Product Portfolio
  18. 8.3.5 Diagnostic Green Recent Developments
  19. 8.4 SERB
  20. 8.4.1 SERB Company Information
  21. 8.4.2 SERB Business Overview
  22. 8.4.3 SERB Indocyanine Green Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 SERB Indocyanine Green Product Portfolio
  24. 8.4.5 SERB Recent Developments
  25. 8.5 Daiichi Sankyo Company
  26. 8.5.1 Daiichi Sankyo Company Company Information
  27. 8.5.2 Daiichi Sankyo Company Business Overview
  28. 8.5.3 Daiichi Sankyo Company Indocyanine Green Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Daiichi Sankyo Company Indocyanine Green Product Portfolio
  30. 8.5.5 Daiichi Sankyo Company Recent Developments
  31. 8.6 Santen Pharmaceutical Co., Ltd.
  32. 8.6.1 Santen Pharmaceutical Co., Ltd. Company Information
  33. 8.6.2 Santen Pharmaceutical Co., Ltd. Business Overview
  34. 8.6.3 Santen Pharmaceutical Co., Ltd. Indocyanine Green Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Santen Pharmaceutical Co., Ltd. Indocyanine Green Product Portfolio
  36. 8.6.5 Santen Pharmaceutical Co., Ltd. Recent Developments
  37. 8.7 Aurolab
  38. 8.7.1 Aurolab Company Information
  39. 8.7.2 Aurolab Business Overview
  40. 8.7.3 Aurolab Indocyanine Green Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Aurolab Indocyanine Green Product Portfolio
  42. 8.7.5 Aurolab Recent Developments
  43. 8.8 Yichuang
  44. 8.8.1 Yichuang Company Information
  45. 8.8.2 Yichuang Business Overview
  46. 8.8.3 Yichuang Indocyanine Green Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Yichuang Indocyanine Green Product Portfolio
  48. 8.8.5 Yichuang Recent Developments
  49. 8.9 Eisai
  50. 8.9.1 Eisai Company Information
  51. 8.9.2 Eisai Business Overview
  52. 8.9.3 Eisai Indocyanine Green Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Eisai Indocyanine Green Product Portfolio
  54. 8.9.5 Eisai Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Indocyanine Green Value Chain Analysis
  2. 9.1.1 Indocyanine Green Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Indocyanine Green Production Mode & Process
  6. 9.2 Indocyanine Green Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Indocyanine Green Distributors
  9. 9.2.3 Indocyanine Green Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst